The Italy patient support programs market is projected to grow during the forecast period as the demand for patient-centric care is increasing in Italy. PSOLife care by Novartis, Hemozone by BioVIIIx, and Clickservice by Merck are major pharma-sponsored PSPs in Italy.
Italy's Oral Care market was valued at $846 Mn in 2022 and is estimated to expand at a CAGR of 5.7% from 2022 to 2030 and will reach $1317 Mn in 2030. One of the main reasons propelling the growth of this market is the introduction of Increasing Demand for Natural and Organic Products, the ageing population. The market is segmented by type, drug and distribution channel. Some key players in this market are 3M, A-Dec Inc., Biolase Inc., Carestream Health Inc., Dentsply Sirona, and Envista Holdings Corporation among others.
The Italy dental care market is projected to grow from $861 Mn in 2022 to $1,362 Mn in 2030 with a CAGR of 5.9% for the year 2022-2030. Technological advancements such as 3D printing for diagnoses and robotic technologies for prostheses are future drivers for the Italy dental care market.